New coating for hemodialysis catheters to prevent infections.
Ceragenin-based antimicrobial coating to tackle hemodialysis catheter-related infections.
This study is testing a new coating for hemodialysis catheters that helps prevent infections, making it safer and more effective for patients who need dialysis.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | N8 Medical, INC. NIH-funded |
| Lab location | 1 site (Dublin, UNITED STATES) |
| Project ID | NIH-10602612 on NIH RePORTER |
What this research studies
This research focuses on developing a novel antimicrobial coating for hemodialysis catheters using ceragenins, which are designed to mimic natural antimicrobial peptides. The goal is to reduce the risk of catheter-related infections, which are a significant concern for hemodialysis patients. The approach aims to enhance the effectiveness of existing treatments by preventing bacterial growth and sensitizing bacteria to antibiotics. By addressing the limitations of current antimicrobial strategies, this research seeks to improve patient outcomes and reduce healthcare costs associated with infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing hemodialysis who are at risk for catheter-related infections.
Not a fit: Patients who do not use hemodialysis catheters or have alternative treatment options for their kidney condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly lower the incidence of infections related to hemodialysis catheters, improving patient safety and reducing hospitalization costs.
How similar studies have performed: While there have been various approaches to antimicrobial coatings, the use of ceragenins represents a novel strategy that has not been extensively tested in this specific application.
Where this research is happening
Dublin, UNITED STATES
- N8 Medical, INC. — Dublin, United States (Active)
Researchers
- Principal investigator: Brunner, Glenn — N8 Medical, INC.
- Study coordinator: Brunner, Glenn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.